VALARTH See Colgate-Palmolive (India) in the appOpen in app
COLPAL · NSE · Personal Care

Colgate-Palmolive (India) Ltd

What the numbers mean, from its filings and the exchange. Data as of 12 Oct 2026.
Mid Cap · AMFI list Jan-Jun 2026 · Vendor sector: Consumer Defensive
fair low confidence No valuation within 120 days; P/E 36.7 vs peers 34.7 (6th of 9); P/B 30.7 vs peers 11.3 (8th of 9).
Statements through FY2026Prices adjusted for 1 corporate actionNot yet reviewed by the adversarial model

What is Colgate-Palmolive (India)'s share price today?

Colgate-Palmolive (India) last traded at ₹1,767.00 on the NSE, as of 12 Oct 2026, 11:00 pm IST, down 2.8% on the day, down 18.2% over a year. Its 52-week range is ₹1,716 to ₹2,330. The live price is in the app.

₹1,767.00 −2.8% today
−18.2% over 1 year · NSE, as of 12 Oct 2026, 11:00 pm IST
60 month-end closes, 31 Oct 2021 to 30 Sep 2026, adjusted for splits and bonuses
52-week range8% of the way up
Low ₹1,716High ₹2,330

What is Colgate-Palmolive (India)'s market cap?

Colgate-Palmolive (India)'s market capitalisation is about ₹49,442 crore: what it would cost to buy every share at today's price. That makes it the 95th largest mid cap company we cover.

₹49,442 Cr Mid Cap95th largest mid cap company
Mid Cap means the companies ranked 101 to 250 by size, under SEBI's rules. Shares in issue are worked out from the market cap and the price. What market cap tells you →

Key facts

From the exchange
Symbol
NSE: COLPAL
ISIN
INE259A01022
Cap bucket
Mid Cap, 95th largest by market cap
Industry (NSE)
Fast Moving Consumer Goods › Personal Products › Personal Care
Listed since
2007
Futures and options
Traded

Is Colgate-Palmolive (India) overvalued?

Fair, with low confidence: no valuation within 120 days; P/E 36.7 vs peers 34.7 (6th of 9); P/B 30.7 vs peers 11.3 (8th of 9).

Valuation

Latest price and trailing 12 months
P/E 36.69
vs peers 34.7 · 6th of 9
Price divided by last year's earnings per share: how many years of today's profit you pay for. Learn more →
P/B 30.72
vs peers 11.3 · 8th of 9
Price divided by book value per share: what you pay for each rupee of net assets on the balance sheet. Learn more →
Market cap ₹49,442 Cr
Total market value of all shares, in ₹ crore. Learn more →
Dividend yield Not available
Last year's dividends as a share of today's price. Learn more →
PEG (vendor) Not available
P/E divided by the vendor's earnings growth figure, which it does not disclose; a P/E adjusted for how fast profits grow. Learn more →
PEG on our 3-year EPS growth 4.49
P/E divided by the 3-year EPS growth rate from the stored accounts. Learn more →
3 models could be judged
Skipped — Fair value, EPV, Graham number, Graham value, Lynch, Owner earnings: no valuation stored

Our valuation range

🔒 Pro
Value range, implied growth at today's price, and the nine models behind it: in the app.

Is Colgate-Palmolive (India) a quality business?

Quality score 61, 4th of 9 in its peer set; WATCH on 30 of 30 flags judged.

Quality and risk

Data as of 12 Oct 2026
Business quality Not available
The kind of business, which sets the yardstick it is judged by. Learn more →
Quality score 61
vs peers 46.4 · 4th of 9
Returns, margins, leverage and consistency against its peers, out of 100. Learn more →
Risk level WATCH
30 of 30 flags judged
From flags on debt, earnings quality, dilution and price swings. Learn more →

Profitability

ROE 81.6%
vs peers 25.9% · 2nd of 9
Return on equity: profit as a share of shareholders' money. Learn more →
ROCE 104.1%
vs peers 29.2% · 2nd of 9
Return on capital employed: operating profit as a share of all the capital in the business, debt and equity. Learn more →
Profit margin 21.4%
vs peers 18.0% · 2nd of 9
Profit after everything, as a share of revenue. Learn more →
EPS Not available
Profit for each share over the last 12 months.

Scorecard

🔒 Pro
Health scores and red flags with their values and history: in the app.
See the scorecard →
Inside the app

Get a sneak peek of Valarth

Start freeStart free
A Valarth stock page: the share price with its chart and 52-week range, valuation and profitability figures, and a scorecard of health checks.
Stock pagePrice, valuation, profitability and a scorecard of health checks for every company, each figure explained.
The Valarth stock screener: a table of companies with price, market cap, P/E, P/B, PEG, EPS and ROE, and filters down the left.
ScreenerEvery listed company, filtered on 212 figures, each with a plain-language lesson beside it.
The Valarth AI Screener answering 'Which companies will benefit from India's Project 75 submarine programme?' with a basket of four naval shipbuilders and a written thesis.
AI ScreenerAsk a question in plain English, like which companies benefit from India's Project 75. It reads the intent, builds the screen and writes the thesis.
A Valarth business-model card for State Bank of India, with a plain-language summary and statements verified against the filing.
Business modelHow a company makes money and what can hurt it, each statement checked against its annual report.
Valarth's Before the Bell edition, with the day's headline, regulator notes and sector moves.
Before the BellA morning edition before the market opens: what moved, which rule changed, and what it means for your holdings.

Has Colgate-Palmolive (India) made money for shareholders?

Mixed: −18.2% over one year and +1.1% a year over five years.

Shareholder returns

1-year return −18.2%
Price only
What the share price did over the last 12 months. Learn more →
5-year return +1.1% a year
Price only
Yearly average price return over five years, bonuses and splits adjusted. Learn more →
Wealth destroyer Yes
Five-year total return — price CAGR on bonus- and split-adjusted closes plus the dividend yield — below the 7% a bank fixed deposit paid. Learn more →

Returns

3Y and 5Y are yearly averages
1W
+2.4%
1M
−0.1%
3M
−10.2%
6M
−5.1%
1Y
−18.2%
3Y
−5.9%
5Y
+1.1%

Does Colgate-Palmolive (India) pay a dividend?

Colgate-Palmolive (India) last paid ₹24.00 a share, ex-dividend 1 Jun 2026; nothing in the past 12 months counts toward a yield.

Dividends

Per share, by ex-dividend date
1 Jun 2026 · Interim 2₹24.00
3 Nov 2025 · Interim 1₹24.00
28 May 2025 · Interim 2₹27.00
4 Nov 2024 · Interim 1₹24.00
22 May 2024 · Special₹10.00
Payout ratio🔒 In the app
The share of profit paid out as dividends; a very high share leaves little to reinvest.
Dividend growth, 5 years🔒 In the app
How fast the dividend per share has grown a year.
Years without a miss🔒 In the app
How many years in a row a dividend has been paid.

Is Colgate-Palmolive (India) growing?

Revenue 3 years 5.1% a year; profit 3 years 8.2% a year; revenue 5 years 4.2% a year.

Growth

Statements through FY2026 (Mar-26)
Revenue 3 years 5.1% a year
vs peers 6.1% · 5th of 8
Compound annual growth of revenue over three years. Learn more →
Profit 3 years 8.2% a year
vs peers 7.4% · 3rd of 7
Compound annual growth of net profit over three years. Learn more →
Revenue 5 years 4.2% a year
Compound annual growth of revenue over five years. Learn more →
Profit 5 years 4.6% a year
Compound annual growth of net profit over five years. Learn more →
EPS 3 years 8.2% a year
Growth in earnings per share, so dilution counts against the company. Learn more →
EPS 5 years 5.1% a year
Growth in earnings per share over five years, so dilution counts against the company. Learn more →
P/E vs own history -14.6%
vs peers -32.9% · 6th of 7
Today's P/E against its own 5-year median; negative is cheaper than its history. Learn more →

How did Colgate-Palmolive (India) do last quarter?

Colgate-Palmolive (India) reported revenue of ₹1,591 Cr, down 0.1% on a year earlier and a net profit of ₹343 Cr, down 7.8% in the Jun 2026 quarter.

Latest quarter

Jun 2026
Revenue, latest quarter₹1,591 Cr
−0.1% on a year earlier
What the company took in over the quarter.
Net profit, latest quarter₹343 Cr
−7.8% on a year earlier
What was left for shareholders after every cost and tax.

How does Colgate-Palmolive (India) compare with its peers?

Compared with 8 Personal Care; 6th of 9 on P/E; 4th of 9 on quality score.

Compared with 8 Personal Care

8 companies

Colgate-Palmolive (India) against its peers

Largest 8 of 8 peers, by market cap
CompanyMarket capP/EP/BROEROCE1YQuality 🔒Rank 🔒
Colgate-Palmolive (India) Ltd₹49,442 Cr36.730.781.6%104.1%−18.2%
Godrej Consumer Products Ltd₹88,055 Cr46.012.818.7%20.2%−22.5%
Dabur India Ltd₹68,599 Cr34.89.719.9%24.7%−20.7%
Cupid Ltd₹49,228 Cr357.524.827.3%33.3%+636.8%
Gillette India Ltd₹23,141 Cr34.625.066.4%81.5%−25.2%
Procter & Gamble Hygiene and Health Care Ltd₹22,536 Cr28.540.2114.9%136.3%−51.0%
Emami Ltd₹16,126 Cr21.55.427.9%29.1%−31.2%
Honasa Consumer Ltd₹15,281 Cr61.37.014.8%18.2%+65.3%
Bajaj Consumer Care Ltd₹6,622 Cr30.45.724.5%29.3%+90.8%
Peer median—34.711.325.9%29.2%−21.6%
Market cap in rupees crore; P/E and P/B on the latest price; 1Y is the price return over a year. A dash is a figure that does not apply or is not reported.

Full peer comparison

🔒 Pro
Every peer, every figure, the ranks and the quality and forensic scores side by side: in the app.

Who owns Colgate-Palmolive (India)?

Colgate-Palmolive (India) is held by promoters 51.0%, foreign institutions 13.6%, domestic institutions 15.8%.

Shareholding pattern

Latest filing, percent of shares
Promoters51.0%
The founders and controlling group.
Foreign institutions13.6%
Overseas funds investing through the FPI route.
Domestic institutions15.8%
Indian insurers, banks, pension and mutual funds together.
Mutual funds7.2%
Indian mutual fund schemes; part of domestic institutions.
Retail and others17.0%
Individual investors and everyone else.
Promoter shares pledged🔒 In the app
Promoter shares given as collateral for loans; a high share is a risk to watch.
Holding trend🔒 In the app
Whether promoters, foreign funds and mutual funds have been adding or selling over recent quarters.

What do analysts say about Colgate-Palmolive (India)?

27 analysts cover Colgate-Palmolive (India), and the consensus is hold. A consensus is a count of opinions, not a forecast; read it beside the numbers.

Analyst consensus

27 analysts
ConsensusHold
The rating most covering analysts give the share.
Average target price🔒 In the app
The mean of the analysts' 12-month price targets.
Upside to target🔒 In the app
How far the target sits above or below today's price.
Share rating it a buy🔒 In the app
The share of covering analysts with a buy rating.

What does Colgate-Palmolive (India) do and what is it sensitive to?

Colgate-Palmolive (India) Limited sells oral care and personal care products, mainly toothpaste, toothbrushes and Palmolive body and hand wash, through distributors, wholesalers, modern trade, e-commerce and other retailers. Sensitive to: commodity prices (corn, carton board, resins, palm oils).

Business-model card

FY2025 · 44 verified
5Revenue
5Channels
2Regulators
2Reg. dependencies
4Sensitivities
4Costs
3Geographies

Colgate-Palmolive (India) Limited sells oral care and personal care products, mainly toothpaste, toothbrushes and Palmolive body and hand wash, through distributors, wholesalers, modern trade, e-commerce and other retailers. It books revenue when control of goods passes to trade customers, and it also reports small research and development service income.

Revenue engine

5 verified
Personal Care (including Oral Care) segment
The company's only reportable segment, covering oral care and personal care products sold within India.
Toothpaste
Toothpaste is the main oral care product line; the filing reports value growth for the portfolio in FY 2024-25.
Toothbrushes and devices
Toothbrush sales are driven by replacement frequency and premium handles; the filing reports robust growth for FY 2024-25.
2 more statements
Palmolive body wash and hand wash
Personal care line the company is building as a growth category; the filing describes first-time national advertising for it.
Research and Development service income
Income from research and development services is recognised on a cost plus basis under the service contract.

Customers & channels

5 verified
Distributors, wholesalers, modern trade, e-commerce and other retailers
Products reach consumers through a distributor network and a wide set of wholesalers and retailers; end users span urban and rural households.
Trade customers
Revenue is recorded when control transfers to trade customers, net of variable consideration such as trade discounts, volume incentives and promotional costs.
Modern Trade
The filing calls modern trade a critical growth lever and reports coverage expansion through in-store image recognition.
2 more statements
Quick commerce and e-commerce
Emerging platforms used to reach shoppers; the filing gives eCommerce a share of the channel but not of company revenue.
Customer concentration
Credit exposure is spread across a large customer base; most customers pay before shipment.

Regulators

2 verified
Indian tax authorities (under various tax laws)
Interpretation: tax demands are contested by the company, and provisions are booked where an outflow is probable and disclosed as contingent liabilities where possible.
Foreign Exchange Management Act, 1999
Interpretation: the Act governs the foreign currency exposure on imports, exports and service flows; the filing lists it for FDI, ODI and ECB and says those were not applicable in the year.

Regulatory dependencies

2 verified
Revenue recognition under Ind AS 115 with discount and rebate accruals
Interpretation: changes in how discounts and rebates on primary and secondary sales are accrued would move reported net revenue.
MSMED Act, 2006 supplier dues
Interpretation: the Act governs payments to registered micro, small and medium suppliers, so payment terms and dues affect working capital and supplier costs.

Sensitivities

4 verified
Commodity prices (corn, carton board, resins, palm oils)
Commodity price increases raise raw material costs; the filing puts a 1% increase at about H 556 lakhs of additional loss.
Foreign exchange rates
Interpretation: currency moves change the cost of imported raw materials and equipment, expatriate costs and export revenue.
FMCG category demand
Interpretation: weaker category conditions reduce volume growth; the filing says FMCG faced headwinds in the second half of FY 2025.
1 more statement
Consumption stimulus and interest rates
Interpretation: policy easing and budget measures aimed at consumption are expected to support recovery in household demand.

Cost inputs

4 verified
Commodity raw materials: corn, carton board, resins, palm oils
Purchased raw materials whose prices drive the commodity price risk the company reports.
Supplier base (77.0%)
Interpretation: a concentrated group of 83 suppliers accounts for 77% of spend, so disruption at these suppliers would hit supply.
Cost-reduction programmes on direct materials and packaging
Revenue Growth Management and Funding the Growth programmes target raw material substitution, reduced packaging and supplier consolidation.
1 more statement
Advertising and promotion spend
Advertising spend rose to support innovation and brand health; promotion costs are netted against revenue as variable consideration.

Geographies

3 verified
India (domestic)
Operations and sales are within India; the company states that performance is driven mainly by local sales.
Exports (4.0%)
A small export share of total turnover; the percentage is given after the question in the filing.
Rural markets
Smaller packs and promotional packaging are used to expand rural distribution and penetration.
Each statement is checked word for word against the FY2025 annual report; the passages are in the app.

What changed recently?

Q1 FY2027 results filed (29 Jul 2026).

Change log

8 entries · newest first
  1. Results filedQ1 FY2027 results filed.
  2. Corporate actionInterim Dividend - Rs 24 Per Share.
  3. Results filedQ4 FY2026 results filed.
  4. Results filedQ3 FY2026 results filed.
  5. Corporate actionInterim Dividend - Rs 24 Per Share.
  6. Results filedQ2 FY2026 results filed.
  7. Results filedQ1 FY2026 results filed.
  8. Corporate actionInterim Dividend - Rs 27 Per Share.
Get alerts →Sign in to be told when any of these change.

What this page does not tell you

What could not be judged, and why. Never empty.
  • Models not runFair value, EPV, Graham number, Graham value, Lynch, Owner earnings: no valuation stored.
  • FlagsWATCH on 30 of 30 flags judged; 1 red.
  • Data gapsDividend yield, PEG (vendor), Business quality, EPS: not available yet.

What this page rests on

✓10 years of annual statements, through FY2026 (Mar-26)✓10 quarters of results✓226 months of month-end prices, adjusted for bonuses and splits (1 corporate action)○no valuation of ours yet✓business-model card FY2025 · 44 verified

Questions people ask

What is Colgate-Palmolive (India)'s share price today?

Colgate-Palmolive (India) last traded at ₹1,767.00 on the NSE, as of 12 Oct 2026, 11:00 pm IST, down 2.8% on the day, down 18.2% over a year. Its 52-week range is ₹1,716 to ₹2,330. The live price is in the app.

What is Colgate-Palmolive (India)'s market cap?

Colgate-Palmolive (India)'s market capitalisation is about ₹49,442 crore: what it would cost to buy every share at today's price. That makes it the 95th largest mid cap company we cover.

Is Colgate-Palmolive (India) Ltd a large cap, mid cap or small cap?

Colgate-Palmolive (India) Ltd (COLPAL) is a mid cap company in AMFI's classification for Jan-Jun 2026. SEBI's buckets go by rank on six-month average market capitalisation: the top 100 are large caps, 101 to 250 mid caps, the rest small caps.

What is Colgate-Palmolive (India) Ltd's P/E ratio?

36.69, vs peers 34.7 · 6th of 9. Price divided by last year's earnings per share: how many years of today's profit you pay for.

Is Colgate-Palmolive (India) Ltd overvalued?

Fair, with low confidence: no valuation within 120 days; P/E 36.7 vs peers 34.7 (6th of 9); P/B 30.7 vs peers 11.3 (8th of 9).

How does Colgate-Palmolive (India) Ltd make money?

Colgate-Palmolive (India) Limited sells oral care and personal care products, mainly toothpaste, toothbrushes and Palmolive body and hand wash, through distributors, wholesalers, modern trade, e-commerce and other retailers. It books revenue when control of goods passes to trade customers, and it also reports small research and development service income.

Who are Colgate-Palmolive (India) Ltd's peers?

Compared with 8 Personal Care: Godrej Consumer Products Ltd, Dabur India Ltd, Cupid Ltd, Gillette India Ltd, Procter & Gamble Hygiene and Health Care Ltd and 3 more. The app shows how they compare on every figure.

Is this investment advice?

No. Valarth is a research and learning tool and is not a SEBI-registered investment adviser or research analyst. The figures come from the company's filings and the exchanges; what to do with them is your call.

How did Colgate-Palmolive (India) do last quarter?

Colgate-Palmolive (India) reported revenue of ₹1,591 Cr, down 0.1% on a year earlier and a net profit of ₹343 Cr, down 7.8% in the Jun 2026 quarter.

Who owns Colgate-Palmolive (India)?

Colgate-Palmolive (India) is held by promoters 51.0%, foreign institutions 13.6%, domestic institutions 15.8%.

Does Colgate-Palmolive (India) pay a dividend?

Colgate-Palmolive (India) last paid ₹24.00 a share, ex-dividend 1 Jun 2026; nothing in the past 12 months counts toward a yield.

What do analysts say about Colgate-Palmolive (India)?

27 analysts cover Colgate-Palmolive (India), and the consensus is hold. A consensus is a count of opinions, not a forecast; read it beside the numbers.

Everything on Colgate-Palmolive (India), and 6,621 other companies, with 212 filters and the full peer tables

See Colgate-Palmolive (India) in the app →See pricing